Coronavirus Disease COVID 19 News and Research

Latest Coronavirus Disease COVID 19 News and Research

Lancet issues correction on paper than prompted WHO to suspend Hydroxychloroquine trial

The World Health Organization (WHO) suspended the hydroxychloroquine trial amid the coronavirus pandemic. The decision comes after the study findings published in The Lancet reported issues on the drug's efficacy and safety. Now, the journal has issued a correction on the figures reported in the study.

2 Jun 2020

Study highlights the importance of research-based healthcare in Germany

The authors recommend a needs-based system focusing on patient well-being and quality assurance, rather than a primarily profit-oriented approach. It should appreciate all employees and integrate innovations as well as digital solutions.

2 Jun 2020

SARS-CoV-2 started spreading in the United States in January, CDC says

The United States has reported the highest number of infections across the globe, with more than 1.81 million confirmed cases and at least 105,000 deaths. The magnitude of the novel coronavirus spread hints that the virus may have started earlier than previously thought.

2 Jun 2020

COVID-19 has become less deadly in Italy, health expert says

Italy was one of the hardest-hit countries amid the coronavirus pandemic. Now, health experts say that the novel coronavirus is losing its potency and has become less deadly.

2 Jun 2020

SARS-CoV-2 emergence could be due to genetic selection and recombination

Researchers have found that genetic selection and recombination could be behind the emergence of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that leads to acute respiratory distress syndrome (ARDS) or COVID-19 disease. This research could explain COVID-19 pandemic and its emergence. The study titled, “Emergence of SARS-CoV-2 through recombination and strong purifying selection,” was published in the journal Science Advances.

1 Jun 2020

Study maps novel coronavirus infection in cells of nasal cavity, airway and lungs

In a major scientific study published in the journal Cell, scientists at the UNC School of Medicine and the UNC Gillings School of Global Public Health have characterized the specific ways in which SARS-CoV-2 – the coronavirus that causes COVID-19 – infects the nasal cavity to a great degree – replicating specific cell types – and infects and replicates progressively less well in cells lower down the respiratory tract, including the lungs.

1 Jun 2020

Crucial ingredient from University of Kansas included in authorized COVID-19 drug

When the Food and Drug Administration issued an emergency-use authorization for the investigational pharmaceutical remdesivir to treat COVID-19 on May 1, in part it was due to pioneering work performed by pharmaceutical chemists at the University of Kansas School of Pharmacy in 1990.

1 Jun 2020

COVID-19 pandemic has worsened pre-existing mental health conditions

With over 6.26 million cases and 375,000 deaths in just five months, the COVID-19 pandemic has caused great fear and devastation in many parts of the world. Many studies show that, generally, there has been an accompanying increase in fear, anxiety, and depressive symptoms during this period. Now, a new study published on the online preprint server medRxiv in May 2020 shows that patients with a history of mental ill-health often underwent a worsening of their symptoms with the onset of the pandemic.

1 Jun 2020

Study reveals how essential SARS-CoV-2 protein can be stabilized and scaled for production

A research group from the University of Texas in Austin described a high-yield production of a stabilized severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein (S-protein) that may accelerate the development of vaccines and diagnostic tests. This methodological 'tour de force' paper is currently available on the bioRxiv* preprint server.

1 Jun 2020

A handheld ultraviolet light device to kill novel coronavirus may be feasible

A personal, handheld device emitting high-intensity ultraviolet light to disinfect areas by killing the novel coronavirus is now feasible, according to researchers at Penn State, the University of Minnesota and two Japanese universities.

1 Jun 2020

Computer modeling reveals necessary vaccine efficacy threshold to prevent SARS-CoV-2 spread

A recent US study showed that in order to prevent or largely extinguish the coronavirus disease 2019 (COVID-19) outbreak without social distancing or any other measures, any vaccine would have to have an efficacy of at least 70%. The research paper is currently available on the medRxiv* preprint server.

1 Jun 2020

Study could make genetic testing more accessible to women

Genetic testing for cancer risk can significantly improve the prevention or treatment of hereditary cancers, but studies have shown that people who might have a genetic risk often don't get tested.

1 Jun 2020

COVID-19 likely to be a seasonal disease

A study conducted in Sydney during the early epidemic stage of COVID-19 has found an association between lower humidity and an increase in locally acquired positive cases. Researchers discovered a 1 percent decrease in humidity could increase the number of COVID-19 cases by 6 percent.

1 Jun 2020

COVID-19 negatively impacts people with eating disorders

A study analyzing the early impact that coronavirus disease 2019 (COVID-19) is having on people with eating disorders has identified areas where their treatment needs could be better addressed.

1 Jun 2020

COVID-19 transmission unlikely to slow down dramatically during summer months

It is well known that rates of transmission of some respiratory viruses, including influenza, tend to fall during the summer months.

1 Jun 2020

SARS-CoV-2 prevalence varies widely across Brazil

Researchers have shown that the prevalence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in Brazil varies significantly by city and region, with the highest prevalence observed in the North of the country and the lowest seen in South and Center-West regions.

1 Jun 2020

NAU scientist collaborating on vault-based vaccine to prevent and treat COVID-19

C. Todd French, assistant professor of biology and leader of Northern Arizona University's new COVID-19 Testing Service Center, is working with scientists at Vault Pharma, an emerging biotechnology company, to test candidate vaccines against the novel coronavirus.

1 Jun 2020